Nkarta Inc at Needham Healthcare Conference (Virtual) Transcript
Good afternoon and welcome to the 21st Needham healthcare conference. My name is Chang Liu and I will be the moderator for this presentation. We welcome Nkarta here today and its CFO, Nadir Mahmood. (Operator Instructions)
Without further ado, Nadir, would you like to start your presentation?
Great. Thank you, Chang, and thank you to yourself and Gil and the team at Needham for the invitation and the opportunity to speak today. Really looking forward to this. So I'm going to be talking today about Nkarta Therapeutics. We are a natural killer cell company designing engineered CAR-NK cells in oncology. As a reminder, I will be making forward-looking statements during the course of my presentation today.
So at Nkarta, we fundamentally believe that what we've built is the next revolution in cell therapy. We have spent the last several years developing and designing a natural killer cell platform to tackle blood cancers and solid tumors
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |